Current ideas on the laboratory diagnosis and treatment of small pelvic inflammatory diseases


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

To paper gives the recent European Guidelines for the management of patients with small pelvic inflammatory diseases, which became available at the website of the International Union against Sexually Transmitted Infections in late 2012. Thus, these are today’s most recent guidelines on this topic, the basis for which are the principles of evidence-based medicine.

Texto integral

Acesso é fechado

Sobre autores

Mikhail Gomberg

Moscow Scientific-and-Practical Center for Dermatovenereology and Cosmetology

MD, PhD, DSc, FRCP London, Chief Researcher, Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, Member AAD, EADV, IUSTI-World Senior Counsellor, IUSTI-Europe Treasurer

Bibliografia

  1. Morcos R., Frost N., Hnat M., Petrunak A., Caldito G. Laparoscopic versus clinical diagnosis of acute pelvic inflammatory disease. J. Reprod. Med. 1993; 38(1): 53-6.
  2. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm. Rep. 2002; 51(RR-6): 1-78.
  3. Judlin P. Current concepts in managing pelvic inflammatory disease. Curr. Opin. Infect. Dis. 2010; 23(1): 83-7.
  4. Haggerty C.L., Totten P.A., Astete S.G., Lee S., Hoferka S.L., Kelsey S.F., Ness R.B. Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. Sex. Transm. Infect. 2008; 84(5): 338-42.
  5. Ness R.B., Trautmann G., Richter H.E., Randall H., Peipert J.F., Nelson D.B. et al. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial. Obstet. Gynecol. 2005; 106(3): 573-80.
  6. Martens M.G., Gordon S., Yarborough D.R., Faro S., Binder D., Berkeley A. Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group. South. Med. J. 1993; 86(6): 604-10.
  7. Judlin P., Liao Q., Liu Z., Reimnitz P., Hampel B., Arvis P. Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study. Br. J. Obstet. Gynaecol. 2010; 117(12): 1475-84.
  8. Walker C.K., Kahn J.G., Washington A.E., Peterson H.B., Sweet R.L. Pelvic inflammatory disease: meta-analysis of antimicrobial regimen efficacy. J. Infect. Dis. 1993; 168(4): 969-78.
  9. Hemsell D.L., Little B.B., Faro S., Sweet R.L., Ledger W.J., Berkeley A.S. et al. Comparison of three regimens recommended by the Centers for Disease Control and Prevention for the treatment of women hospitalized with acute pelvic inflammatory disease. Clin. Infect. Dis. 1994; 19(4): 720-7.
  10. Witte E.H., Peters A.A., Smit I.B., van der Linden M.C., Mouton R.P., van der Meer J.W., van Erp E.J. A comparison of pefloxacin/metronidazole and doxycycline/metronidazole in the treatment of laparoscopically confirmed acute pelvic inflammatory disease. Eur. J. Obstet. Gynecol. Reprod. Biol. 1993; 50(2): 153-8.
  11. Heinonen P.K., Teisala K., Miettinen A., Aine R., Punnonen R., Grönroos P. A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease. Scand. J. Infect. Dis. 1989; 60(Suppl.): 66-73.
  12. Bradshaw C.S., Jensen J.S., Tabrizi S.N., Read T.R., Garland S.M., Hopkins C.A. et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg. Infect. Dis. 2006; 12(7): 1149-52.
  13. Heystek M.J., Ross J.D.; PID Study Group. A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease. Int. J. STD AIDS. 2009; 20(10): 690-5.
  14. Ross J.D., Cronjé H.S., Paszkowski T., Rakoczi I., Vildaite D., Kureishi A. et al. Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial. Sex. Transm. Infect. 2006; 82(6): 446-51.
  15. Haggerty C.L., Ness R.B., Amortegui A., Hendrix S.L., Hillier S.L., Holley R.L. et al. Endometritis does not predict reproductive morbidity after pelvic inflammatory disease. Am. J. Obstet. Gynecol. 2003; 188(1): 141-8.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2014